Matinas BioPharma Holdings, Inc. - Common Stock, par value $0.0001 per share (MTNB) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2024 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
MTNB on NYSE
Shares outstanding
5,086,994
Price per share
$0.60
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
330,108
Total reported value
$617,696
% of total 13F portfolios
0%
Share change
+53,722
Value change
+$101,472
Number of holders
28
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Matinas BioPharma Holdings, Inc. - Common Stock, par value $0.0001 per share (MTNB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Sanitam Partners LLC 10% -59% $9,407,694 +$8,732,528 17,104,899 +1293% STERN ADAM K 08 Apr 2025
Pembroke & Partners LLC 10% -50% $9,292,642 +$8,732,528 16,895,712 +1559% Robert J. Eide 08 Apr 2025
Lazar David E. 9.8% $1,144,500 545,000 Lazar David E. 15 Aug 2025
Hezbay Holdings LLC 5% $533,066 253,841 Hezbay Holdings LLC 25 Sep 2025
111 Equity Group 3.6% -31% $101,001 -$43,649 183,639 -30% 111 Equity Group LLC 13 Feb 2025

As of 30 Sep 2025, 28 institutional investors reported holding 330,108 shares of Matinas BioPharma Holdings, Inc. - Common Stock, par value $0.0001 per share (MTNB). This represents 6.5% of the company’s total 5,086,994 outstanding shares.

Institutional Holders of Matinas BioPharma Holdings, Inc. - Common Stock, par value $0.0001 per share (MTNB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 93,545 $55,921 +$239 $0.59 8
2025 Q3 330,108 $617,696 +$101,472 $1.89 28
2025 Q2 276,386 $254,142 -$21,439 $0.89 24
2025 Q1 320,149 $166,481 -$25,649 $0.52 23
2024 Q4 336,793 $177,414 -$555,641 $0.51 18
2024 Q3 535,167 $1,894,530 +$1,718,768 $3.54 16